These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 20878053)

  • 1. Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review).
    Smeenk L; Lohrum M
    Int J Oncol; 2010 Nov; 37(5):1061-70. PubMed ID: 20878053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 family and programmed cell death.
    Pietsch EC; Sykes SM; McMahon SB; Murphy ME
    Oncogene; 2008 Oct; 27(50):6507-21. PubMed ID: 18955976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 family in development.
    Danilova N; Sakamoto KM; Lin S
    Mech Dev; 2008; 125(11-12):919-31. PubMed ID: 18835440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG.
    Amin AR; Thakur VS; Paul RK; Feng GS; Qu CK; Mukhtar H; Agarwal ML
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5419-24. PubMed ID: 17369354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the p53-MDM2 pathway.
    Åberg E; Saccoccia F; Grabherr M; Ore WYJ; Jemth P; Hultqvist G
    BMC Evol Biol; 2017 Aug; 17(1):177. PubMed ID: 28774266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data.
    Sbisà E; Catalano D; Grillo G; Licciulli F; Turi A; Liuni S; Pesole G; De Grassi A; Caratozzolo MF; D'Erchia AM; Navarro B; Tullo A; Saccone C; Gisel A
    BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S20. PubMed ID: 17430565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy.
    Napoli M; Flores ER
    Br J Cancer; 2017 Jan; 116(2):149-155. PubMed ID: 27884017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFκB/p53 crosstalk-a promising new therapeutic target.
    Schneider G; Krämer OH
    Biochim Biophys Acta; 2011 Jan; 1815(1):90-103. PubMed ID: 20951769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 pathway: positive and negative feedback loops.
    Harris SL; Levine AJ
    Oncogene; 2005 Apr; 24(17):2899-908. PubMed ID: 15838523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The common and distinct target genes of the p53 family transcription factors.
    Harms K; Nozell S; Chen X
    Cell Mol Life Sci; 2004 Apr; 61(7-8):822-42. PubMed ID: 15095006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of flotillin-2, a major protein on lipid rafts, as a novel target of p53 family members.
    Sasaki Y; Oshima Y; Koyama R; Maruyama R; Akashi H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
    Mol Cancer Res; 2008 Mar; 6(3):395-406. PubMed ID: 18296650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation of p53 function and promoter selectivity by post-translational modifications].
    Tanaka T
    Seikagaku; 2010 Mar; 82(3):200-9. PubMed ID: 20408452
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of p53--insights into a complex process.
    Boehme KA; Blattner C
    Crit Rev Biochem Mol Biol; 2009; 44(6):367-92. PubMed ID: 19929178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53; from inductive signal to cellular effect.
    Hansen R; Oren M
    Curr Opin Genet Dev; 1997 Feb; 7(1):46-51. PubMed ID: 9024633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical induced alterations in p53 signaling.
    Högberg J; Silins I; Stenius U
    EXS; 2009; 99():181-208. PubMed ID: 19157062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk of Notch with p53 and p63 in cancer growth control.
    Dotto GP
    Nat Rev Cancer; 2009 Aug; 9(8):587-95. PubMed ID: 19609265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients.
    Ding L; Zhang Z; Xu Y; Zhang Y
    Bioengineered; 2017 Jul; 8(4):383-392. PubMed ID: 28075663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.